As the tumor hypoxia is a spatiotemporal variable during cancer development, HIF1α responds rapidly to hypoxia but also to re-oxygenation, making it quite unstable in the context of clinical sample collection [57], which may question the role of HIF1α as a marker to detect hypoxia in clinical material. The gene discussed is HIF1A; the disease is cancer.